PAVmed (PAVM) COO receives 110,000-share restricted stock grant vesting 2029

Rhea-AI Filing Summary

O'Neil Shaun reported acquisition or exercise transactions in this Form 4 filing.

PAVmed Inc. Chief Operating Officer Shaun O'Neil received a grant of 110,000 shares of common stock as restricted stock under the company's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan. The award has a single vesting date of May 20, 2029 and is subject to forfeiture if the required service period is not completed. Following this grant, O'Neil directly holds 115,598 shares of PAVmed common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider O'Neil Shaun

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	110,000	$0.00	--

Holdings After Transaction: Common Stock — 115,598 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 110,000 shares Grant price per share: $0.00 per share Shares held after grant: 115,598 shares +1 more

4 metrics

Restricted stock grant 110,000 shares Common Stock awarded to COO on April 2, 2026

Grant price per share $0.00 per share Stated transaction price for restricted stock

Shares held after grant 115,598 shares Total direct PAVmed common stock holdings after transaction

Vesting date May 20, 2029 Single vesting date for restricted stock grant

Key Terms

restricted stock, Long-Term Incentive Equity Plan, vesting date, forfeiture

4 terms

restricted stock financial

"Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Long-Term Incentive Equity Plan financial

"under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan"

vesting date financial

"with a single vesting date of May 20, 2029"

forfeiture financial

"Such restricted stock is subject to forfeiture if the requisite service period is not completed."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neil Shaun

(Last) (First) (Middle)

360 MADISON AVENUE, 25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PAVmed Inc. [ PAVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		110,000(1)	A	$0(1)	115,598	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

	/s/ Michael A. Gordon, by power of attorney	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PAVmed (PAVM) report for Shaun O'Neil?

PAVmed reported that Chief Operating Officer Shaun O'Neil received a grant of 110,000 shares of restricted common stock. The shares were awarded at a stated price of $0.00 per share under the company’s long-term incentive equity plan.

How many PAVmed shares does Shaun O'Neil hold after this Form 4 grant?

After the restricted stock grant, Shaun O'Neil directly holds 115,598 shares of PAVmed common stock. This total reflects his position immediately following the award, as disclosed in the Form 4 insider trading report.

When do Shaun O'Neil’s new PAVmed restricted shares vest?

The 110,000 restricted shares granted to Shaun O'Neil have a single vesting date of May 20, 2029. Vesting requires completion of the specified service period, or the restricted stock may be forfeited under the plan’s terms.

What is the nature of the PAVmed stock grant reported in this Form 4?

The filing describes the transaction as a grant or award acquisition of common stock. It is restricted stock issued under PAVmed’s Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan, rather than an open-market purchase or sale.

Is the PAVmed COO’s restricted stock grant subject to forfeiture?

Yes. The 110,000 restricted shares granted to the PAVmed Chief Operating Officer are subject to forfeiture. If the requisite service period through May 20, 2029 is not completed, the restricted stock can be forfeited according to the footnote disclosure.